Inside the VCX Stock Crash: Why Retail Investors Chased a Fund Trading at 16x NAV

Every discussion about VCX these days is accompanied by a chart that resembles a seismograph during an earthquake more than a typical trading pattern. Ten days later, it was $575, up from $31.21 in the middle of March. After that, it fell back into the double digits. The stock closed at $89.74 on Thursday, down 3.41% for the session. By Friday morning, it had dropped an additional percent to $88.33. One of the most bizarre tales in recent market memory can be found somewhere in that arc.

It was never intended for Fundrise Innovation Fund to become a meme. It’s a venture capital fund, the type of structure that typically sits quietly in institutional portfolios, working slowly on private investments in the middle and late stages. Stakes in OpenAI, Anthropic, and allegedly some exposure to SpaceX were what set VCX apart and ultimately made it explosive. That read like a cheat code to ordinary investors who are barred from private markets. That’s where the frenzy began.

An already raging fire was fueled by the OpenAI news in early April. VCX briefly became the most popular ticker on the NYSE after Fundrise announced its involvement in the $122 billion OpenAI funding round. After observing the premium to net asset value ratio, which momentarily surpassed 16x, Jim Cramer referred to it as “pure lunacy.” He was correct. A fund is not a stock if it sells for sixteen times the value of its underlying holdings. It’s a wager that the same paper will cost even more to someone else. That math is the foundation of bubbles.

The unwind arrived quickly. In a single period, VCX lost more than 30%. Depending on the day you begin counting, the one-month return is -71.51%. Bloomberg published an article about the “post-listing reversal.” Updates with increasingly tired headlines continued to be published by TipRanks. Throughout it all, the CEO of Fundrise defended the idea on CNBC, telling viewers that venture capital should be part of a diversified portfolio. You make a valid point. It’s another matter entirely whether VCX at $575 was ever the best way to obtain that exposure.

Almost as fascinating as the chart itself is what’s going on beneath the price action. Form 144 notices to resell shares have been filed by sellers; in one recent filing, 39,285 shares through Jefferies were disclosed along with several other resales. That’s normal plumbing for a direct listing, but it also indicates that supply is continuing to enter a market that is obviously reaching its limit. On certain days, the bid-ask has been virtually nonexistent, serving as a reminder that ranges like $85.70 to $93.94 on a quiet Thursday are the result of thin liquidity in both directions.

DXYZ, or Destiny Tech100, is another proxy vehicle for SpaceX and private AI exposure that is frequently compared. In comparison to NAV, both funds trade at premiums. The same retail cohort is drawn to both. This spring, both have imparted a costly lesson: premiums can rise and fall terribly quickly when there is no simple way to arbitrage the price against the real underlying assets. It’s an old pattern dressed up. This is how closed-end fund dynamics have always operated. The audience is what has changed.

It’s difficult not to feel sorry for the late buyers as you watch this play out. It’s not illegal to want exposure to Anthropic or OpenAI if you’re not a billionaire; it’s a legitimate goal. Simply put, the fund structure wasn’t designed to handle the momentum it generated. Within VCX, there is still a legitimate business, legitimate holdings, and a potential five-year thesis outline. However, with supply pressure evident in the filings and an exceptional 52-week range still visible on the chart, the stock will need to regain confidence gradually at $89 and change. That is most likely healthy. It’s definitely less enjoyable.